Lobbying

Cadence's latest lobbying report covers Q2 2026, at $35K. The four quarters Q4 2025–Q3 2026 total $105K. Its first report covers Q1 2024; the issues it reports most are Medicare/Medicaid.

Cadence

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$105K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q1 2024
The first quarter a report named it

Lobbying by quarter

Cadence lobbying by quarter
Cadence lobbying by quarter
QuarterAmountReports
Q1 2024$15K1
Q2 2024$15K1
Q3 2024$15K1
Q4 2024$15K1
Q1 2025$35K1
Q2 2025$35K1
Q3 2025$35K1
Q4 2025$35K1
Q1 2026$35K1
Q2 2026$35K1
Q3 2026$00

By issue

  • Medicare and Medicaid$270K · 10 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)10 reports
  • HOUSE OF REPRESENTATIVES10 reports
  • SENATE10 reports

Firms it paid

Firm
Sirona Strategies$270K10 quarters

Former officials lobbying for it

Former position
KATIE VINSONIntern, Office of National Drug Control Policy, Executive Office of the PresidentQ2 2026
KRISTA DROBACSchedule C/Sr Advisor, Centers for Medicare/Medicaid Services; Legis. Asst., Sen. Durbin; Fellow, Sen. StabenowQ2 2026

Lobbying reports

Filed by
07/20for Q2Sirona Strategies$35K
04/20for Q1Sirona Strategies$35K
01/20for Q4 2025Sirona Strategies$35K
25/10/20for Q3 2025Sirona Strategies$35K
25/07/22for Q2 2025Sirona Strategies$35K
25/04/18for Q1 2025Sirona Strategies$35K
25/01/23for Q4 2024Sirona Strategies$15K
24/10/21for Q3 2024Sirona Strategies$15K
24/07/22for Q2 2024Sirona Strategies$15K
24/04/22for Q1 2024Sirona Strategies$15K
24/03/15for Q1 2024Sirona StrategiesUnder $5,000